13F-HR filed by EcoR1 Capital, LLC
EcoR1 Capital, LLC filed this 13F-HR for the quarter ended 2021-12-31, filed 2022-02-14, with 76 holding rows worth $3,138,062,000.
- Accession
- 0001567619-22-003866
- Filer
- CIK 1587114
- Filed
- 2022-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2021
A holdings report, 76 entries on the cover page, a total value of $3,138,062,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $3,138,062,000 with VALUE read as thousands by filing date, 13F file number 028-16764. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| PROTHENA CORP PLC SHS | G72800108 | Stock | 11,284,280 | $557,443,000 | thousands by filing date | |
| ANAPTYSBIO INC | 032724106 | COM | 7,521,024 | $261,356,000 | thousands by filing date | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 5,523,358 | $223,530,000 | thousands by filing date | |
| XENCOR INC | 98401F105 | COMMON STOCK | 4,906,106 | $196,833,000 | thousands by filing date | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 4,033,882 | $190,722,000 | thousands by filing date | |
| MORPHIC HLDG INC | 61775R105 | COM | 3,951,566 | $187,225,000 | thousands by filing date | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 2,224,403 | $122,631,000 | thousands by filing date | |
| NUVATION BIO INC COM CL A | 67080N101 | Stock | 13,896,543 | $118,121,000 | thousands by filing date | |
| ALECTOR INC | 014442107 | COMMON STOCK | 4,994,970 | $103,146,000 | thousands by filing date | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 2,639,706 | $90,278,000 | thousands by filing date | |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 1,077,483 | $81,652,000 | thousands by filing date | |
| GRITSTONE BIO INC | 39868T105 | COM | 6,012,232 | $77,317,000 | thousands by filing date | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 3,060,593 | $71,434,000 | thousands by filing date | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 2,759,505 | $65,593,000 | thousands by filing date | |
| ITEOS THERAPEUTICS INC | 46565G104 | COM | 1,303,157 | $60,675,000 | thousands by filing date | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 1,779,084 | $54,636,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 3,724,437 | $52,142,000 | thousands by filing date | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 3,468,944 | $50,993,000 | thousands by filing date | |
| 2SEVENTY BIO INC COMMON STOCK | 901384107 | Stock | 1,917,063 | $49,134,000 | thousands by filing date | |
| ATEA PHARMACEUTICALS INC | 04683R106 | COMMON STOCK | 5,376,134 | $48,063,000 | thousands by filing date | |
| DESIGN THERAPEUTICS INC | 25056L103 | COM | 2,152,997 | $46,096,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 940,636 | $40,015,000 | thousands by filing date | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 1,411,975 | $27,858,000 | thousands by filing date | |
| PARDES BIOSCIENCES INC | 69945Q105 | COM | 1,597,139 | $26,145,000 | thousands by filing date | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 1,300,000 | $25,818,000 | thousands by filing date | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 1,279,175 | $19,546,000 | thousands by filing date | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 6,082,200 | $19,524,000 | thousands by filing date | |
| AKOUOS INC | 00973J101 | COM | 1,975,984 | $16,796,000 | thousands by filing date | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 590,169 | $16,767,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 98,146 | $16,644,000 | thousands by filing date | |
| SOLID BIOSCIENCES INC COM NEW | 83422E105 | Stock | 9,202,702 | $16,105,000 | thousands by filing date | |
| HALOZYME THERAPEUTICS INC COM | 40637H109 | Stock | 392,000 | $15,762,000 | thousands by filing date | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 307,594 | $14,337,000 | thousands by filing date | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 1,300,000 | $14,222,000 | thousands by filing date | |
| ERASCA INC COM | 29479A108 | Stock | 700,000 | $10,906,000 | thousands by filing date | |
| ARVINAS INC | 04335A105 | COM | 130,300 | $10,703,000 | thousands by filing date | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 882,176 | $9,933,000 | thousands by filing date | |
| IMMUNOVANT INC | 45258J102 | COM | 1,140,819 | $9,720,000 | thousands by filing date | |
| VOYAGER THERAPEUTICS INC | 92915B106 | COMMON STOCK | 3,557,507 | $9,641,000 | thousands by filing date | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 309,540 | $8,961,000 | thousands by filing date | |
| GRAPHITE BIO INC | 38870X104 | COM | 688,900 | $8,563,000 | thousands by filing date | |
| NUVATION BIO INC | 67080N119 | WARR | 963,333 | $8,188,000 | thousands by filing date | |
| ARS PHARMACEUTICALS INC | 82835W108 | COM | 1,060,010 | $7,060,000 | thousands by filing date | |
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 200,000 | $6,440,000 | thousands by filing date | |
| FRAZIER LIFESCIENCES ACQU CO | G3710A105 | CMN | 587,615 | $5,729,000 | thousands by filing date | |
| APPLIED MOLECULAR TRANS INC | 03824M109 | COM | 400,000 | $5,592,000 | thousands by filing date | |
| KRONOS BIO INC | 50107A104 | COM | 387,357 | $5,264,000 | thousands by filing date | |
| JIYA ACQUISITION CORP | 47760M102 | CMN | 500,000 | $4,885,000 | thousands by filing date | |
| NEOLEUKIN THERAPEUTICS INC | 64049K104 | COM | 860,619 | $4,148,000 | thousands by filing date | |
| HEALTH SCIENCES ACQ CORP 2 | G4411D109 | ORD SHS | 400,000 | $4,032,000 | thousands by filing date | |
| GRITSTONE BIO INC | 39868T105 | COM | 307,000 | $3,948,000 | thousands by filing date | call |
| AC IMMUNE SA | H00263105 | SHS | 749,585 | $3,710,000 | thousands by filing date | |
| VERVE THERAPEUTICS INC | 92539P101 | COM | 100,000 | $3,687,000 | thousands by filing date | |
| KINNATE BIOPHARMA INC | 49705R105 | COM | 175,000 | $3,101,000 | thousands by filing date | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 215,000 | $2,556,000 | thousands by filing date | |
| MOONLAKE IMMUNOTHERAPEUTICS | G4444C102 | COM | 200,000 | $1,978,000 | thousands by filing date | |
| 5 01 ACQUISITION CORP | 33836P105 | CMN | 200,000 | $1,970,000 | thousands by filing date | |
| BCLS ACQUISITION CORP | G0904B105 | CMN | 200,000 | $1,960,000 | thousands by filing date | |
| EUCRATES BIOMEDICAL ACQU COR | G3141W106 | CMN | 200,000 | $1,952,000 | thousands by filing date | |
| Adverum Biotechnologies, Inc. | 00773U108 | Common Stock | 1,046,700 | $1,842,000 | thousands by filing date | |
| ARYA SCIENCES ACQU CORP IV | G31659108 | COM | 150,000 | $1,487,000 | thousands by filing date | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 50,000 | $1,155,000 | thousands by filing date | |
| CARIBOU BIOSCIENCES INC COM | 142038108 | Stock | 75,000 | $1,132,000 | thousands by filing date | |
| ALIGOS THERAPEUTICS INC COM NEW | 01626L105 | Stock | 91,044 | $1,081,000 | thousands by filing date | |
| REPARE THERAPEUTICS INC | 760273102 | COM | 50,000 | $1,055,000 | thousands by filing date | |
| TURMERIC ACQUISITION CORP | G9127T108 | CMN | 100,000 | $982,000 | thousands by filing date | |
| VTV THERAPEUTICS INC CL A | 918385105 | Stock | 834,333 | $830,000 | thousands by filing date | |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 37,593 | $768,000 | thousands by filing date | |
| CAREMAX INC | 14171W111 | *W EXP 06/08/202 | 100,000 | $768,000 | thousands by filing date | |
| BOLT BIOTHERAPEUTICS INC | 097702104 | COM | 150,000 | $735,000 | thousands by filing date | |
| EUCRATES BIOMEDICAL ACQU COR | G3141W122 | *W EXP 10/23/202 | 66,666 | $651,000 | thousands by filing date | |
| FRAZIER LIFESCIENCES ACQU CO | G3710A113 | WTS | 66,665 | $650,000 | thousands by filing date | |
| VAXCYTE INC COM | 92243G108 | Stock | 20,800 | $495,000 | thousands by filing date | |
| OMEGA ALPHA SPAC | G6749V107 | CL A | 50,000 | $489,000 | thousands by filing date | |
| SURROZEN INC | 86889P117 | *W EXP 08/01/203 | 66,665 | $429,000 | thousands by filing date | |
| TURMERIC ACQUISITION CORP | G9127T124 | WTS | 33,333 | $327,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001567619-22-003866 | this filing | 2022-02-14 | acceptance time not in the bulk data set |